CN110711217A - 一种治疗手足口病疱疹性咽峡炎疱疹病毒性角膜炎及口腔溃疡的中药组合物 - Google Patents
一种治疗手足口病疱疹性咽峡炎疱疹病毒性角膜炎及口腔溃疡的中药组合物 Download PDFInfo
- Publication number
- CN110711217A CN110711217A CN201810761970.1A CN201810761970A CN110711217A CN 110711217 A CN110711217 A CN 110711217A CN 201810761970 A CN201810761970 A CN 201810761970A CN 110711217 A CN110711217 A CN 110711217A
- Authority
- CN
- China
- Prior art keywords
- parts
- ethanol
- traditional chinese
- chinese medicine
- foot
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 65
- 208000020061 Hand, Foot and Mouth Disease Diseases 0.000 title claims abstract description 13
- 208000025713 Hand-foot-and-mouth disease Diseases 0.000 title claims abstract description 13
- 208000002399 aphthous stomatitis Diseases 0.000 title claims abstract description 12
- 208000007117 Oral Ulcer Diseases 0.000 title claims abstract description 11
- 239000000203 mixture Substances 0.000 title abstract description 20
- 208000005100 Herpetic Keratitis Diseases 0.000 title description 10
- 206010073938 Ophthalmic herpes simplex Diseases 0.000 title description 10
- 206010002383 Angina Pectoris Diseases 0.000 title description 6
- 201000010884 herpes simplex virus keratitis Diseases 0.000 title description 3
- 239000008187 granular material Substances 0.000 claims abstract description 31
- 239000003826 tablet Substances 0.000 claims abstract description 28
- 239000002775 capsule Substances 0.000 claims abstract description 27
- 201000006219 Herpangina Diseases 0.000 claims abstract description 10
- 239000000843 powder Substances 0.000 claims abstract description 10
- 238000007796 conventional method Methods 0.000 claims abstract description 9
- 206010023332 keratitis Diseases 0.000 claims abstract description 9
- 239000006187 pill Substances 0.000 claims abstract description 7
- 241000175212 Herpesvirales Species 0.000 claims abstract description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 97
- 239000000284 extract Substances 0.000 claims description 43
- 238000002156 mixing Methods 0.000 claims description 38
- 239000002994 raw material Substances 0.000 claims description 25
- 238000001035 drying Methods 0.000 claims description 24
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 24
- 239000007788 liquid Substances 0.000 claims description 22
- 238000000034 method Methods 0.000 claims description 22
- 238000002360 preparation method Methods 0.000 claims description 19
- 238000001914 filtration Methods 0.000 claims description 18
- 229920002472 Starch Polymers 0.000 claims description 17
- 239000000706 filtrate Substances 0.000 claims description 17
- 239000008107 starch Substances 0.000 claims description 17
- 235000019698 starch Nutrition 0.000 claims description 17
- 238000010298 pulverizing process Methods 0.000 claims description 16
- 229940079593 drug Drugs 0.000 claims description 15
- 235000013399 edible fruits Nutrition 0.000 claims description 15
- 239000008194 pharmaceutical composition Substances 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 239000011248 coating agent Substances 0.000 claims description 12
- 238000000576 coating method Methods 0.000 claims description 12
- 235000019359 magnesium stearate Nutrition 0.000 claims description 12
- 238000010992 reflux Methods 0.000 claims description 12
- 235000006533 astragalus Nutrition 0.000 claims description 11
- 230000001954 sterilising effect Effects 0.000 claims description 11
- 238000007873 sieving Methods 0.000 claims description 10
- 238000002791 soaking Methods 0.000 claims description 10
- 241001061264 Astragalus Species 0.000 claims description 9
- 210000004233 talus Anatomy 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 8
- 229940107666 astragalus root Drugs 0.000 claims description 6
- 238000009835 boiling Methods 0.000 claims description 6
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 6
- 239000007924 injection Substances 0.000 claims description 5
- 238000002347 injection Methods 0.000 claims description 5
- 239000002552 dosage form Substances 0.000 claims description 4
- 208000020670 canker sore Diseases 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 241000555682 Forsythia x intermedia Species 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- 239000009636 Huang Qi Substances 0.000 abstract description 16
- 230000000694 effects Effects 0.000 abstract description 4
- 239000002671 adjuvant Substances 0.000 abstract 1
- 231100000957 no side effect Toxicity 0.000 abstract 1
- 239000007901 soft capsule Substances 0.000 abstract 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 11
- 208000025865 Ulcer Diseases 0.000 description 10
- 231100000397 ulcer Toxicity 0.000 description 10
- 241000555712 Forsythia Species 0.000 description 9
- 238000003756 stirring Methods 0.000 description 9
- 208000002193 Pain Diseases 0.000 description 8
- 229940126680 traditional chinese medicines Drugs 0.000 description 8
- 238000000605 extraction Methods 0.000 description 7
- 239000003889 eye drop Substances 0.000 description 7
- 229940012356 eye drops Drugs 0.000 description 7
- GUTLYIVDDKVIGB-OUBTZVSYSA-N Cobalt-60 Chemical compound [60Co] GUTLYIVDDKVIGB-OUBTZVSYSA-N 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 5
- 125000001475 halogen functional group Chemical group 0.000 description 5
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 5
- 239000000811 xylitol Substances 0.000 description 5
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 5
- 229960002675 xylitol Drugs 0.000 description 5
- 235000010447 xylitol Nutrition 0.000 description 5
- 206010037660 Pyrexia Diseases 0.000 description 4
- 210000001217 buttock Anatomy 0.000 description 4
- 230000003628 erosive effect Effects 0.000 description 4
- 210000002683 foot Anatomy 0.000 description 4
- 210000004247 hand Anatomy 0.000 description 4
- 238000009210 therapy by ultrasound Methods 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 3
- 239000003937 drug carrier Substances 0.000 description 3
- FAOZLTXFLGPHNG-KNAQIMQKSA-N fluorometholone Chemical compound C([C@@]12C)=CC(=O)C=C1[C@@H](C)C[C@@H]1[C@]2(F)[C@@H](O)C[C@]2(C)[C@@](O)(C(C)=O)CC[C@H]21 FAOZLTXFLGPHNG-KNAQIMQKSA-N 0.000 description 3
- 229960001048 fluorometholone Drugs 0.000 description 3
- 210000000214 mouth Anatomy 0.000 description 3
- 235000001075 Abelmoschus manihot Nutrition 0.000 description 2
- 240000005959 Abelmoschus manihot Species 0.000 description 2
- 241000213006 Angelica dahurica Species 0.000 description 2
- 241000205585 Aquilegia canadensis Species 0.000 description 2
- 241000045403 Astragalus propinquus Species 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- 244000111489 Gardenia augusta Species 0.000 description 2
- 235000018958 Gardenia augusta Nutrition 0.000 description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 description 2
- 206010067152 Oral herpes Diseases 0.000 description 2
- 206010039085 Rhinitis allergic Diseases 0.000 description 2
- 206010039424 Salivary hypersecretion Diseases 0.000 description 2
- 201000010105 allergic rhinitis Diseases 0.000 description 2
- 201000009361 ascariasis Diseases 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 239000007919 dispersible tablet Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 208000030194 mouth disease Diseases 0.000 description 2
- 210000002200 mouth mucosa Anatomy 0.000 description 2
- 201000009240 nasopharyngitis Diseases 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 208000026451 salivation Diseases 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- -1 tabletting Substances 0.000 description 2
- NLVFBUXFDBBNBW-PBSUHMDJSA-N tobramycin Chemical compound N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N NLVFBUXFDBBNBW-PBSUHMDJSA-N 0.000 description 2
- 229960000707 tobramycin Drugs 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 244000307697 Agrimonia eupatoria Species 0.000 description 1
- 241000244186 Ascaris Species 0.000 description 1
- 244000003416 Asparagus officinalis Species 0.000 description 1
- 235000005340 Asparagus officinalis Nutrition 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 235000011274 Benincasa cerifera Nutrition 0.000 description 1
- 244000036905 Benincasa cerifera Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 235000005747 Carum carvi Nutrition 0.000 description 1
- 240000000467 Carum carvi Species 0.000 description 1
- 235000004032 Centella asiatica Nutrition 0.000 description 1
- 244000146462 Centella asiatica Species 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000035851 Chrysanthemum leucanthemum Species 0.000 description 1
- 244000037185 Cinnamomum burmannii Species 0.000 description 1
- 235000014487 Cinnamomum burmannii Nutrition 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 241000675108 Citrus tangerina Species 0.000 description 1
- GJSURZIOUXUGAL-UHFFFAOYSA-N Clonidine Chemical compound ClC1=CC=CC(Cl)=C1NC1=NCCN1 GJSURZIOUXUGAL-UHFFFAOYSA-N 0.000 description 1
- 241000212948 Cnidium Species 0.000 description 1
- 241000742679 Coprosma repens Species 0.000 description 1
- 241000037740 Coptis chinensis Species 0.000 description 1
- 241000218176 Corydalis Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000709687 Coxsackievirus Species 0.000 description 1
- 240000000774 Cunila origanoides Species 0.000 description 1
- 235000018274 Cunila origanoides Nutrition 0.000 description 1
- 244000301850 Cupressus sempervirens Species 0.000 description 1
- 241001523681 Dendrobium Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 235000014866 Dictamnus albus Nutrition 0.000 description 1
- 235000015489 Emblica officinalis Nutrition 0.000 description 1
- 241001529459 Enterovirus A71 Species 0.000 description 1
- 241000305599 Erigeron annuus Species 0.000 description 1
- 241000208368 Euonymus alatus Species 0.000 description 1
- 241001547125 Fritillaria thunbergii Species 0.000 description 1
- 240000004859 Gamochaeta purpurea Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 244000224182 Gomphrena globosa Species 0.000 description 1
- 241000096284 Gynochthodes officinalis Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 208000009889 Herpes Simplex Diseases 0.000 description 1
- 208000029433 Herpesviridae infectious disease Diseases 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 235000002710 Ilex cornuta Nutrition 0.000 description 1
- 241001310146 Ilex cornuta Species 0.000 description 1
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 description 1
- GSDSWSVVBLHKDQ-JTQLQIEISA-N Levofloxacin Chemical compound C([C@@H](N1C2=C(C(C(C(O)=O)=C1)=O)C=C1F)C)OC2=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-JTQLQIEISA-N 0.000 description 1
- 241000830535 Ligustrum lucidum Species 0.000 description 1
- 235000003956 Luffa Nutrition 0.000 description 1
- 244000280244 Luffa acutangula Species 0.000 description 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 1
- 244000050983 Luffa operculata Species 0.000 description 1
- 241000195954 Lycopodium clavatum Species 0.000 description 1
- 241000219071 Malvaceae Species 0.000 description 1
- 241000361919 Metaphire sieboldi Species 0.000 description 1
- 244000235756 Microcos paniculata Species 0.000 description 1
- 229930195210 Ophiopogon Natural products 0.000 description 1
- 244000248557 Ophiopogon japonicus Species 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 235000010326 Osmanthus heterophyllus Nutrition 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 241000283966 Pholidota <mammal> Species 0.000 description 1
- 241000132171 Phryma leptostachya Species 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 241001300674 Plukenetia volubilis Species 0.000 description 1
- 235000008599 Poria cocos Nutrition 0.000 description 1
- 244000197580 Poria cocos Species 0.000 description 1
- 244000234609 Portulaca oleracea Species 0.000 description 1
- 235000001855 Portulaca oleracea Nutrition 0.000 description 1
- 241000206469 Pulsatilla Species 0.000 description 1
- 241001448537 Reineckea Species 0.000 description 1
- 240000008254 Rosa chinensis Species 0.000 description 1
- 235000000664 Rosa chinensis Nutrition 0.000 description 1
- 241000304195 Salvia miltiorrhiza Species 0.000 description 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 description 1
- 240000002800 Sanicula europaea Species 0.000 description 1
- 240000003705 Senecio vulgaris Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 241000219784 Sophora Species 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 240000006688 Telosma cordata Species 0.000 description 1
- 235000017352 Telosma cordata Nutrition 0.000 description 1
- 244000191422 Terminalia bellirica Species 0.000 description 1
- 235000011517 Terminalia chebula Nutrition 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000009818 Trichosanthes kirilowii Nutrition 0.000 description 1
- 240000006023 Trichosanthes kirilowii Species 0.000 description 1
- 241000746716 Typhonium Species 0.000 description 1
- 206010064996 Ulcerative keratitis Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 240000008866 Ziziphus nummularia Species 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 208000005298 acute pain Diseases 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 229960002896 clonidine Drugs 0.000 description 1
- 235000000125 common agrimony Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 201000007717 corneal ulcer Diseases 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000000256 facial nerve Anatomy 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000007888 film coating Substances 0.000 description 1
- 238000009501 film coating Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000010440 gypsum Substances 0.000 description 1
- 229910052602 gypsum Inorganic materials 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 229960003376 levofloxacin Drugs 0.000 description 1
- 235000011477 liquorice Nutrition 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 235000008113 selfheal Nutrition 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000009495 sugar coating Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- BPJYAXCTOHRFDQ-UHFFFAOYSA-L tetracopper;2,4,6-trioxido-1,3,5,2,4,6-trioxatriarsinane;diacetate Chemical compound [Cu+2].[Cu+2].[Cu+2].[Cu+2].CC([O-])=O.CC([O-])=O.[O-][As]1O[As]([O-])O[As]([O-])O1.[O-][As]1O[As]([O-])O[As]([O-])O1 BPJYAXCTOHRFDQ-UHFFFAOYSA-L 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Biophysics (AREA)
- Ophthalmology & Optometry (AREA)
- Otolaryngology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明公开了一种治疗手足口病、疱疹性咽峡炎、疱疹病毒性角膜炎、口腔溃疡的中药组合物。该中药组合物由黄芪、连翘、乌梅组成。加入常规辅料,按照常规工艺可制成片剂、颗粒剂、胶囊剂、散剂、软胶囊剂、滴丸剂等。本发明中药组合物治疗手足口病、疱疹性咽峡炎、疱疹病毒性角膜炎、口腔溃疡效果显著且无副作用。
Description
技术领域
本发明涉及含有黄芪连翘乌梅的中药组合物的新用途。属于药物制剂领域。
背景技术
自从申请人公布申请号为:201510582314.1。发明名称为:一种治疗过敏性鼻炎和皮肤过敏的中药组合物以来,在诊所为更多的患者治疗过敏性鼻炎的同时,发现本组合物对手足口病疱疹性咽峡炎疱疹病毒性角膜炎及口腔溃疡有非常好的治疗效果。检索文献发现,据《中国药典》乌梅;敛肺,涩肠,生津,安蛔。用于肺虚久咳,久痢滑肠,虚热消渴,蛔厥呕吐腹痛,胆道蛔虫症。中国专利文献公开了申请号:201110404777.0,发明名称为:一种治疗手足口病的中药制剂,其中内服药:金银花梢4~6g、连翘4~6g、淡豆豉3~4g、栀子3~4g、生地黄2~4g、乌梅2~4g、太子参3~5g、麦门冬2~4g、石.斛3~4g、生山枣仁2~3g、夏枯草2~4g、赤芍2~4g、大贝母2~4g、香白芷(不可炒)2~4g、黄芪3~4g、鸡血藤2~3g、茯苓2~4g、生甘草2~3克;外用药:金银花15g、连翘花15g、紫花地丁10g、香白芷10g、栀子10g。中国专利文献还公开了申请号:201410136001.9,发明名称为:一种治疗疱疹性咽峡炎的药物组合物,它是由下列原料药制成:三爪金龙、一匹草、一年蓬、人头七、大尾摇、木棉花、大叶蛇总管、布渣叶、山花生、女贞子、山青皮、千日红、乌梅、女娄菜、白头翁、五月茶、水红花子、丝瓜络、牛含水、四季青、长年兰、小驳骨、火油草、冬瓜皮、水亚木、天冬、石筋草、石上开花、地龙、白牛胆、吉祥草、巴戟天、老头草、五加皮、白鲜皮、伤寒草、月季花、华卫矛、阴香皮和毛诃子。中国专利文献还公开了申请号:201310067565.7,发明名称为:一种利用黄葵治疗单纯疱疹的散剂,其各原料组分的重量配比为:黄葵28-32、青黛13-17、人参8-12、黄柏8-12、丝瓜藤2-6、雷公根6-10、泽兰2-6、马齿苋3-7、穿山甲2-6、五倍子3-7、槐花1-5、白鲜皮18-22、乌梅8-12、煅石膏45-55、知母8-12。中国专利文献还公开了申请号;201510139242.3,发明名称为:一种治疗口腔溃疡的中药,其组成原料的重量份为:野菊花11-13、黄芪3-5、竹叶8-10、丹参2-4、玄参5-7、黄连3-4、生地2-4、知母5-8、炙甘草10-12、乌梅4-5、升麻2-4、肉桂8-10、仙鹤草2-4、连翘1-3、胡麻仁2-4、焦三仙5-6、防风2-3、元胡4-5、香花菜2-4、小麦麸1-3和小叶桑根2-4;
发明内容
本发明的技术方案是这样实现的:这种药物组合物的组成或原料药组成包括临床上合理剂量的黄芪、连翘、乌梅的组合制剂。所述的药物组合物的组成的比例或原料药组成包括:黄芪3-30重量份或克;连翘1-20重量份或克;乌梅3-40重量份或克。
其中所述的连翘可以用连翘提取物代替;黄芪可以用黄芪提取物代替;丹参可以用丹参提取物代替;其他类同。
所述中药原料按照常规方法,加入或不加入常规辅料制成药剂学上可接受的剂型,包括但不限于汤剂、口服液、胶囊、片剂、颗粒剂、滴丸或散剂制剂。
本发明的中药组合物的制备方法,是由所述原料用不同工艺、不同提取方法得到的各药物提取物的混合物,或药物分成几个不同组分经分别提取后的提取物的混合物,或总提取物,制成的制剂。
本发明的所述的中药组合物,它是由所述重量配比的原料制成的任何一种药剂学上所说的剂型,包含汤剂,口服液、散剂、片剂、胶囊、分散片、微丸、滴丸、注射剂、颗粒剂。
本发明的所述的中药组合物的制备方法,它包括将所述中药原料直接切成小块或粉碎成粗粉,再用水或乙醇提取得到的各药物提取物,或继续浓缩成干浸膏,或者再与药剂学上可接受的载体混合。
本发明的所述的中药组合物的制备方法可以是,将中药材原料用水煎煮1-3次,每次10-30分钟,滤过,合并滤液,滤液减压浓缩至每1毫升相当于生药材量1克,即得汤剂;或经灭菌,灌瓶,即得口服液;或者浓缩、干燥至干膏,加入淀粉,粉碎,混匀,过80目筛,用95%乙醇湿法制粒,80℃以下干燥,整粒,制成颗粒剂;或者常规方法加入硬脂酸镁,混匀,压片,包衣,即得片剂;或者加入常规赋形剂,装入胶囊,即得胶囊剂。或者:将中药原料用乙醇浸泡8-12小时后,用20~25重量倍75~85%乙醇分1-3次回流,每次微沸后回流1~1.5小时,滤过,回收乙醇至无醇味,得提取物;按常规方法制成汤剂、口服液、颗粒剂、片剂、丸剂、散剂、注射剂或胶囊剂。
本发明的中药组合物的制备方法优选为,将连翘、黄芪、乌梅用水煎煮3次,每次20分钟,滤过,合并滤液,滤液浓缩至1/2体积,减压浓缩至每1毫升相当于生药材量1克,即得汤剂;或经灭菌,灌瓶,即得口服液;或者浓缩至稠膏,继续减压干燥至干膏,加入淀粉,粉碎,混匀,过80目筛,用95%乙醇湿法制粒,80℃以下干燥,整粒,制成颗粒剂;或者硬脂酸镁,混匀,压片,包衣,即得片剂;或者加入赋形剂,装入胶囊,即得胶囊剂。
或者将连翘、黄芪、乌梅用乙醇浸泡12小时后,用25倍量75~85%乙醇2次回流,每次微沸后回流1~1.5小时,滤过,回收乙醇至无醇味,得提取物;按上述方法制成汤剂、口服液、颗粒剂、片剂、胶囊剂。
或者按配方颗粒常规提取方法分别提取连翘、乌梅、黄芪。取其提取物混合。按上述方法制成汤剂、口服液、颗粒剂、片剂、胶囊剂。
本发明的中药组合物的制备方法优选为,将连翘、黄芪、乌梅用水煎煮3次,每次20分钟,滤过,合并滤液,滤液浓缩至1/2体积,减压浓缩至每1毫升相当于生药材量1克,即得汤剂;或经灭菌,灌瓶,即得口服液;或者浓缩至稠膏,继续减压干燥至干膏,加入淀粉,粉碎,混匀,过80目筛,用95%乙醇湿法制粒,80℃以下干燥,整粒,制成颗粒剂;或者硬脂酸镁,混匀,压片,包衣,即得片剂;或者加入赋形剂,装入胶囊,即得胶囊剂。
或者将连翘、黄芪、乌梅用乙醇浸泡12小时后,用25倍量75~85%乙醇2次回流,每次微沸后回流1~1.5小时,滤过,回收乙醇至无醇味,得提取物;按上述方法制成汤剂、口服液、颗粒剂、片剂、胶囊剂。
或者按配方颗粒常规提取方法分别提取连翘、乌梅、黄芪。取其提取物混合。按上述方法制成汤剂、口服液、颗粒剂、片剂、胶囊剂。
本发明的中药组合物是由上述重量配比的原料药或者还有药学上可以接受的载体制成的任何一种药剂学上所说的剂型,包含汤剂、散剂、片剂、胶囊、分散片、微丸、注射剂、口服液、颗粒剂。
本发明的药剂学上可以接受的载体包括但不限于:赋形剂,如淀粉及其衍生物、糊精、磷酸氢钙、硬脂酸镁、微粉硅胶等;崩解剂,如羧甲基纤维素钠、羟丙基纤维素等;润滑剂,如硬脂酸镁等;包糖衣材料,如蔗糖、滑石粉、明胶、色素、川蜡等;薄膜包衣材料,如胃溶型水、醇包衣材料等。
本发明药物组合物的应用包括可以用于治疗手足口病疱疹性咽峡炎溃疡性角膜炎及口腔溃疡。
下述实验例用于进一步说明本发明。
下述试验例和实施例进一步证明但不限于本发明:
实验例1
随机选取40例来诊所就诊的手足口病患者,分成两组,年龄和性别大致相当。分别采用专利申请号为201110404777.0的组方煎剂治疗(按其说明书公布的煎剂制备方法和服药方法)和本发明组方治疗(由实施例1的方法制备,40克生药成人用量,婴幼儿佐情减量),结果所有患者均在一周内痊愈。因本发明组方中药味数和服用量显著低于对照组,所以本发明组方更有优势。
实验例2
随机选取30例来诊所就诊的疱疹性咽峡炎患者,分成两组,年龄和性别大致相当。分别采用专利申请号为201410136001.9的组方煎剂治疗(按其说明书公布的煎剂制备方法和服药方法)和本发明组方治疗(由实施例1的方法制备,40克生药成人用量,婴幼儿佐情减量),结果所有患者均在一周内痊愈。因本发明组方中药味数和服用量显著低于对照组,所以本发明组方更有优势。
实验例3
随机选取10例来诊所就诊的疱疹病毒性角膜炎患者,分成两组,年龄和性别大致相当。分别采用专利申请号为201310067565.7的组方煎剂治疗(按其说明书公布的煎剂制备方法和服药方法)和本发明组方治疗(由实施例1的方法制备,40克生药成人用量,婴幼儿佐情减量),结果所有患者均在一周内痊愈。因本发明组方中药味数和服用量显著低于对照组,所以本发明组方更有优势。
实验例4
随机选取30例来诊所就诊的顽固性口腔溃疡患者,分成两组,年龄和性别大致相当。分别采用专利申请号为201510139242.3的组方煎剂治疗(按其说明书公布的煎剂制备方法和服药方法)和本发明组方治疗(由实施例1的方法制备,40克生药成人用量,婴幼儿佐情减量),结果所有患者均在一周内痊愈。因本发明组方中药味数和服用量显著低于对照组,所以本发明组方更有优势。
典型病例
典型病例(手足口病)
病例一
刘某,女,4岁,2014年6月就诊,患者母亲代诉:2天前感冒伴发热,在社区医院拿小儿感冒颗粒口服、不见好转,今天早上不愿进食且流口水,手、足和臀部出现斑丘疹、疱疹。查体:口腔疱疹已破溃、有一片状的糜烂面,手、足和臀部疱疹周围可有炎性红晕。实验室检查:查到柯萨奇病毒A16型。患者母亲要求服用本发明中药每天四次,每次1/2袋,五天后临床症状完全消失,实验室检查恢复正常,未再见复发。
病例二
董某,女,5岁,于2015年5月就诊,家长代诉该托儿所有流行手足口病,3天来,手、足和臀部出现斑丘疹、疱疹,质地较硬,周围有红晕,伴头痛,乏力。实验室检查;查到肠道病毒71型(EV 71)。患者家长要求服用本发明中药本发明中药每天四次,每次1/2袋,五天后,临床症状完全消失,实验室检查恢复正常,未再见复发。
病例三
赵某某,女,2岁,患者于2015年5月就诊,家长代诉4天前,发烧,自行服用小儿退热栓和抗病毒药片用后好转,昨天早上以来,出现手、足和臀部出现斑疱疹增多,纳少、腹泻水样便。查体:体温正常,口腔疱疹已形成灰白色膜,有的疱疹已破,有渗液流出。患者家长要求服本发明中药本发明中药每天四次,每次1/2袋,五天后,临床症状完全消失,未再见复发。
典型病例(疱疹性咽峡炎)
病例四
邢某某,女,5岁,于2015年9月就诊,家长代诉该托儿所有流行疱疹性咽峡炎,初起,发热、咽痛、流涎、拒食、烦躁不安,咽部充血,口腔黏膜出现灰白色疱疹,周围绕以红晕。3日后红晕加剧扩大,疱疹破渍形成黄色溃疡。患者家长要求服用本发明中药本发明中药每天四次,每次1/2袋,五天后,临床症状完全消失,实验室检查恢复正常,未再见复发。
病例五
马某某,男,5岁,于2015年9月就诊,上述邢X X同学,家长代诉该托儿所有流行疱疹性咽峡炎,初起,发热、咽痛、流涎、拒食、烦躁不安,咽部充血,口腔黏膜出现灰白色疱疹,周围绕以红晕。3日后红晕加剧扩大,疱疹破溃形成黄色溃疡。患者家长要求服用本发明中药本发明中药每天四次,每次1/2袋,五天后,临床症状完全消失,实验室检查恢复正常,未再见复发。
典型病例(疱疹病毒性角膜炎)
病例六
潘某某,男,38岁,2005年因为右眼红肿、刺痛、见光痛加剧,到北大医院眼科就诊,医生诊断为单纯疱疹病毒性角膜炎,给予氟米龙滴眼液和左氧氟沙星滴眼液(可乐必妥)一周后痊愈。以后每当休息不好或过于疲劳,均引发单纯疱疹病毒性角膜炎,患者自行购买氟米龙滴眼液和妥布霉素滴眼液治疗,但痊愈时间延长,要半个月才愈。2014年,患者单纯疱疹病毒性角膜炎再次复发,经朋友推荐找到发明者本人,给于本发明中药每天四次,每次1袋,三天痊愈。以后又三次单纯疱疹病毒性角膜炎发作,均服用本发明中药,三天到五天痊愈,近二年未再复发。
病例七
赵某某,男,48岁,十多年前电焊灼伤过眼睛,后因疱疹病毒感染引起面部神经痉挛并做过手术。因为左眼红肿、刺痛、见光痛加剧,到晋城大医院眼科就诊,医生诊断为单纯疱疹病毒性角膜炎,给予营养输液,氟米龙滴眼液和妥布霉素滴眼液一周后痊愈。2015年,患者单纯疱疹病毒性角膜炎再次复发,经朋友推荐找到发明者本人,给于本发明中药每天四次,每次1袋,三天痊愈。近三年未再复发。
典型病例(顽固性口腔溃疡)
病例八
张某某,女,40岁,患有口腔溃疡半年,口腔颊部两侧及舌之两侧均匀溃疡,患者大便干结,舌质红,苔黄厚,脉洪滑等,服用本发明的中药中药每天四次,每次1袋,七天后溃疡面基本愈合,症状消失。
病例九
陈某某,女,35岁,患有口腔溃疡一年,口腔颊部两侧糜烂、疼痛;多方治疗后反复复,不得根治,后将本发明的中药中药每天四次,每次1袋,使用一周后,溃疡面明显缩小,两颊糜烂程度好转,疼痛症状缓解,继续服用十天以巩固疗效,治愈。
病例十
魏某,女,16岁,患有口腔溃疡多年,舌尖、口腔颊部两侧溃疡处糜烂、疼痛难忍,溃疡周围黏膜充血呈红晕状,溃疡周围粘膜充血呈红晕状,服用本发明中药每天四次,每次1袋,使用五天后,溃疡面明显缩小,疼痛减轻,继续服用五天,溃疡面愈合。
按照后文实施例2到实施例10所制的样品都能实现实验例1实验例2实验例3实验例4的效果。
实施例1
取连翘30克、乌梅30克、黄芪30克每次20分钟,过滤,合并滤液。减压浓缩至每1毫升相当于生药材量1克,即得汤剂,或者钴60辐照灭菌后,灌瓶,即得口服液。
或者,所得到的提取浓缩物继续减压干燥至干膏,加入适量淀粉,粉碎,混匀,过80目筛,用95%乙醇湿法制粒,80℃以下干燥,整粒,制成颗粒剂;或者加入适量的硬脂酸镁,混匀,压片,包衣即得片剂。
或者,所得到的提取浓缩物,继续减压干燥至干膏,加入适量淀粉,粉碎,混匀,制成颗粒,干燥,装入胶囊,即得胶囊剂。
实施例2:
取连翘40克、乌梅20克、黄芪30克用水煎煮3次,每次20分钟,过滤,合并滤液,滤液浓缩至1/5体积备用;减压浓缩至每1毫升相当于生药材量1克,将15克木糖醇加入,搅匀,即得汤剂,或者钴60辐照灭菌后,灌瓶,即得口服液。
或者按实施例1所述的方法制成颗粒剂、片剂或胶囊剂。
实施例3:
取连翘50克、乌梅30克、黄芪25克用水煎煮2次,每次60分钟,分次滤过,合并滤液,浓缩至相对密度为1.20~1.25(75~80℃测)的清膏,冷至40℃时,搅拌下缓缓加入乙醇,使含醇量达75%,充分搅拌,静置12小时,滤取上清液,残渣加75%乙醇适量,搅匀,静置12小时,滤过,合并乙醇液,回收乙醇至无醇味,将15克木糖醇加入,再加入纯净水,每1毫升相当于生药材量1克,搅匀,即得汤剂,或者钴60辐照灭菌后,灌瓶,即得口服液。
或者减压浓缩成稠膏,低温干燥,粉碎,加淀粉适量,混匀,(或用乙醇制粒,干燥。)制成颗粒剂、片剂或胶囊剂。
实施例4:
取连翘30克、乌梅50克、黄芪30克用20~25倍量75%乙醇分两次浸泡超声,每次浸泡24小时,然后超声1小时,滤过,回收乙醇至无醇味,得提取物;将15克木糖醇和提取物混合,加适量蒸馏水;减压浓缩至每1毫升相当于生药材量1克,,搅匀,即得汤剂,或者钴60辐照灭菌后,灌瓶,即得口服液。
或者按实施例1所述的方法制成颗粒剂、片剂或胶囊剂。
实施例5:
取连翘35克、乌梅40克、黄芪30克用20~25倍量75%乙醇分两次浸泡超声,每次浸泡24小时,然后超声1小时,滤过,回收乙醇至无醇味,得提取物;将15克木糖醇和提取物混合,加适量蒸馏水;减压浓缩至每1毫升相当于生药材量1克,,搅匀,即得汤剂,或者钴60辐照灭菌后,灌瓶,即得口服液。
或者按实施例1所述的方法制成颗粒剂、片剂或胶囊剂。
实施例6:
取连翘40克、乌梅40克、黄芪20克用乙醇浸泡12小时后,用20~25倍量75~85%乙醇分两次回流,每次微沸后回流1小时,滤过,回收乙醇至无醇味,得提取物;将15克木糖醇和提取物混合,加适量蒸馏水;减压浓缩至每1毫升相当于生药材量1克,,搅匀,即得汤剂,或者钴60辐照灭菌后,灌瓶,即得口服液。
或者按实施例1所述的方法制成颗粒剂、片剂或胶囊剂。
实施例7:
按配方颗粒常规提取方法分别提取连翘、乌梅、黄芪。取其提取物分别相当于连翘原料40克、乌梅20克、黄芪20克混合。加入适量淀粉,粉碎,混匀,过80目筛,用95%乙醇湿法制粒,80℃以下干燥,整粒,制成颗粒剂;或者加入适量的硬脂酸镁,混匀,压片,包衣即得片剂。
或者将各自提取物混合后,加入适量淀粉,粉碎,混匀,制成颗粒,干燥,装入胶囊,即得胶囊剂。
实施例8
按配方颗粒常规提取方法分别提取连翘、赤芍、黄芪。取其提取物分别相当于连翘原料40克、乌梅50克、黄芪20克混合。加入适量淀粉,粉碎,混匀,过80目筛,用95%乙醇湿法制粒,80℃以下干燥,整粒,制成颗粒剂;或者加入适量的硬脂酸镁,混匀,压片,包衣即得片剂。
或者将各自提取物混合后,加入适量淀粉,粉碎,混匀,制成颗粒,干燥,装入胶囊,即得胶囊剂。
实施例9
按配方颗粒常规提取方法分别提取连翘、乌梅、黄芪。取其提取物分别相当于连翘原料40克、乌梅40克、黄芪20克。加入适量淀粉,粉碎,混匀,过80目筛,用95%乙醇湿法制粒,80℃以下干燥,整粒,制成颗粒剂;或者加入适量的硬脂酸镁,混匀,压片,包衣即得片剂。
或者将各自提取物混合后,加入适量淀粉,粉碎,混匀,制成颗粒,干燥,装入胶囊,即得胶囊剂。
实施例10
按配方颗粒常规提取方法分别提取连翘、乌梅、黄芪。取其提取物分别相当于连翘原料20克、乌梅30克、黄芪20克混合。加入适量淀粉,粉碎,混匀,过80目筛,用95%乙醇湿法制粒,80℃以下干燥,整粒,制成颗粒剂;或者加入适量的硬脂酸镁,混匀,压片,包衣即得片剂。
或者将各自提取物混合后,加入适量淀粉,粉碎,混匀,制成颗粒,干燥,装入胶囊,即得胶囊剂。
以上所述,仅为本发明的较佳实施例,并非对本发明作任何形式上和实质上的限制,凡熟悉本专业的技术人员,在不脱离本发明技术方案范围内,当可利用以上所揭示的技术内容,而做出的些许更动、修饰与演变的等同变化,均为本发明的等效实施例;同时,凡依据本发明的实质技术对以上实施例所作的任何等同变化的更动、修饰与演变,均仍属于本发明的技术方案的范围内。
Claims (9)
1.一种治疗手足口病、疱疹性咽峡炎、疱疹病毒性角膜炎、口腔溃疡的药物组合物,其特征在于制备其有效成分的原料为:黄芪3-30重量份;连翘1-20重量份;乌梅3-40重量份。
2.根据权利要求1所述的治疗手足口病、疱疹性咽峡炎、疱疹病毒性角膜炎、口腔溃疡的药物组合物,其中制备其有效成分的原料为:
黄芪10重量份、连翘10重量份、乌梅10重量份;
黄芪8重量份、连翘18重量份、乌梅14重量份;
黄芪20重量份、连翘10重量份、乌梅10重量份;
或黄芪6重量份、连翘10重量份、乌梅24重量份。
3.根据权利要求1-2任一所述的治疗手足口病、疱疹性咽峡炎、疱疹病毒性角膜炎、口腔溃疡的药物组合物,其特征在于所述手足口病、疱疹性咽峡炎、疱疹病毒性角膜炎及口腔溃疡是病毒引起。
4.根据权利要求1-2任一所述的药物组合物的制备方法,其特征在于该方法为:将所述中药原料按照常规方法,加入或不加入常规辅料制成药剂学上可接受的剂型,包括但不限于汤剂、口服液、胶囊、片剂、颗粒剂、滴丸或散剂制剂。
5.根据权利要求1-2任一所述的药物组合物的制备方法,其特征在于该方法为:将中药材原料用水煎煮1-3次,每次10-30分钟,滤过,合并滤液,滤液减压浓缩至每1毫升相当于生药材量1重量份,即得汤剂;或经灭菌,灌瓶,即得口服液;或者浓缩、干燥至干膏,加入淀粉,粉碎,混匀,过80目筛,用95%乙醇湿法制粒,80℃以下干燥,整粒,制成颗粒剂;或者常规方法加入硬脂酸镁,混匀,压片,包衣,即得片剂;或者加入常规赋形剂,装入胶囊,即得胶囊剂。
6.根据权利要求1-2任一所述的药物组合物的制备方法,其特征在于该方法为:将中药原料用乙醇浸泡8-12小时后,用20~25重量倍75~85%乙醇1-3次回流,每次微沸后回流1~1.5小时,滤过,回收乙醇至无醇味,得提取物;按常规方法制成汤剂、口服液、颗粒剂、片剂、丸剂、散剂、注射剂或胶囊剂。
7.根据权利要求3所述的药物组合物的制备方法,其特征在于该方法为:将中药材原料用水煎煮1-3次,每次10-30分钟,滤过,合并滤液,滤液减压浓缩至每1毫升相当于生药材量1重量份,即得汤剂;或经灭菌,灌瓶,即得口服液;或者浓缩、干燥至干膏,加入淀粉,粉碎,混匀,过80目筛,用95%乙醇湿法制粒,80℃以下干燥,整粒,制成颗粒剂;或者常规方法加入硬脂酸镁,混匀,压片,包衣,即得片剂;或者加入常规赋形剂,装入胶囊,即得胶囊剂。
8.根据权利要求3所述的药物组合物的制备方法,其特征在于该方法为:将中药原料用乙醇浸泡8-12小时后,用20~25重量倍75~85%乙醇分两次回流,每次微沸后回流1~1.5小时,滤过,回收乙醇至无醇味,得提取物;按常规方法制成汤剂、口服液、颗粒剂、片剂、丸剂、散剂、注射剂或胶囊剂。
9.根据权利要求1-2任一所述的药物组合物在制备治疗手足口病、疱疹性咽峡炎、疱疹病毒性角膜炎及口腔溃疡的药物中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810761970.1A CN110711217A (zh) | 2018-07-12 | 2018-07-12 | 一种治疗手足口病疱疹性咽峡炎疱疹病毒性角膜炎及口腔溃疡的中药组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810761970.1A CN110711217A (zh) | 2018-07-12 | 2018-07-12 | 一种治疗手足口病疱疹性咽峡炎疱疹病毒性角膜炎及口腔溃疡的中药组合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110711217A true CN110711217A (zh) | 2020-01-21 |
Family
ID=69209060
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810761970.1A Pending CN110711217A (zh) | 2018-07-12 | 2018-07-12 | 一种治疗手足口病疱疹性咽峡炎疱疹病毒性角膜炎及口腔溃疡的中药组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110711217A (zh) |
-
2018
- 2018-07-12 CN CN201810761970.1A patent/CN110711217A/zh active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102370687B (zh) | 一种治疗结肠炎的中药复方制剂及其制备方法 | |
CN103784933B (zh) | 复发性口腔溃疡散 | |
CN101940658A (zh) | 一种治疗牙痛的中药组合物及其制备方法 | |
CN101912577B (zh) | 一种治疗风湿、类风湿疾病的药物及制备工艺 | |
CN101347543A (zh) | 一种中药组合物及其制备方法 | |
CN101683429A (zh) | 防治禽传染性法氏囊病的中兽药颗粒剂及其制备方法 | |
CN102784300A (zh) | 一种治疗牙痛的药物组合物及其制备方法 | |
CN110711217A (zh) | 一种治疗手足口病疱疹性咽峡炎疱疹病毒性角膜炎及口腔溃疡的中药组合物 | |
CN106563076B (zh) | 一种治疗胃病的药物及其制作方法 | |
CN105362645A (zh) | 一种制备治疗口腔炎症的药物组合物的方法 | |
CN101474373A (zh) | 一种治疗急性咽炎的中药 | |
CN101642485B (zh) | 一种含黄芪的药物组合物在制备治疗白细胞减少症、过敏性紫癜症的药物中的应用 | |
CN104274800A (zh) | 治疗胃病的药物及其制备方法 | |
CN100571769C (zh) | 扎木萨-4味的颗粒剂及其制备方法 | |
CN110237119A (zh) | 一种治疗口腔黏膜类疾病的药物组合物及制备方法和用途 | |
CN111000962B (zh) | 治疗脾虚湿困证功能性消化不良的中成药及其制备方法 | |
CN102579801B (zh) | 一种治疗糖尿病综合症的中药制剂及其制备方法 | |
CN102018794A (zh) | 一种治疗月经不调的中药 | |
CN100364596C (zh) | 一种治疗糖尿病的复方蒙药及制备方法 | |
CN110711218A (zh) | 一种治疗嗓子痛咳嗽的中药组合物 | |
CN106421091B (zh) | 一种治疗口腔溃疡的组合物 | |
CN105148078A (zh) | 一种用于治疗口腔溃疡的药物制剂 | |
CN112057578A (zh) | 益精豆丸 | |
CN114732852A (zh) | 一种藏药玛诺系汤便秘通颗粒及其制备方法 | |
CN115192680A (zh) | 一种治疗流感的药物制备方法及其功效 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20200121 |
|
WD01 | Invention patent application deemed withdrawn after publication |